Literature DB >> 11309643

Anxiety at the frontier of molecular medicine.

D R Weinberger1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309643     DOI: 10.1056/NEJM200104193441612

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females.

Authors:  Emily C Bell; Glen B Baker; Christina Poag; Francois Bellavance; Janisse Khudabux; Jean-Michel Le Mellédo
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

2.  Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.

Authors:  Marinos C Dalakas
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.

Authors:  Marinos C Dalakas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

4.  Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system.

Authors:  Dinesh Dhingra; Ritu Chhillar; Arun Gupta
Journal:  Neurochem Res       Date:  2011-10-28       Impact factor: 3.996

5.  The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.

Authors:  Marinos C Dalakas
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

6.  Lipid peroxidation markers in children with anxiety disorders and their diagnostic implications.

Authors:  Mehmet Fatih Ceylan; Esra Guney; Murat Alisik; Merve Ergin; Gulser Senses Dinc; Zeynep Goker; Sevda Eker; Murat Kizilgun; Ozcan Erel
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

Review 7.  Oxidative stress and anxiety: relationship and cellular pathways.

Authors:  Jaouad Bouayed; Hassan Rammal; Rachid Soulimani
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

8.  Involvement of Nrf2 in development of anxiety-like behavior by linking Bcl2 to oxidative phosphorylation: estimation in rat hippocampus, amygdala, and prefrontal cortex.

Authors:  Solmaz Khalifeh; Shahrbanoo Oryan; Hadi Digaleh; Fatemeh Shaerzadeh; Fariba Khodagholi; Nader Maghsoudi; Mohammad-Reza Zarrindast
Journal:  J Mol Neurosci       Date:  2014-07-11       Impact factor: 3.444

9.  Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study.

Authors:  Ella H Sklan; Alexander Lowenthal; Mira Korner; Ya'acov Ritov; Daniel M Landers; Tuomo Rankinen; Claude Bouchard; Arthur S Leon; Treva Rice; D C Rao; Jack H Wilmore; James S Skinner; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

Review 10.  The role of oxidative stress in anxiety disorder: cause or consequence?

Authors:  Alessandra das Graças Fedoce; Frederico Ferreira; Robert G Bota; Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Res       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.